■NEWS: “Base Rate” Assessment Fee Calculation to Start in June, Mid

News Highlights

In a Q&A regarding the 2026 fiscal year medical fee revision, it was indicated that the “Base Rate” assessment fee will be calculated starting in June. Performance data from June and July will be subject to the mid-term report for this calculation. This suggests implications for the medical fee revision process, healthcare facility management strategies, and particularly business succession.

Perspective from M&A Medical Editorial Department

The potential introduction of a new assessment item, the “Base Rate” assessment fee, in the 2026 fiscal year revision signals a shift in the revenue structure of medical institutions. Specifically, the fact that June and July performance will be the basis for the mid-term report implies that medical institutions will need to establish rapid data collection and analysis systems to respond to the pace of the revision. In the context of M&A, it is crucial to assess how this new assessment item will affect future profitability evaluations. For example, if certain departments or services are highly valued under this “Base Rate” assessment fee, the business value of medical institutions with strengths in those areas may relatively increase. Conversely, if the valuation is low, early business restructuring or optimization of the business portfolio through M&A may become essential. Management must closely monitor these revision trends and specifically consider how to integrate them into their own management strategies and business succession plans.

Key Discussion Points from This News

• Introduction of “Base Rate” assessment fee suggests potential changes in healthcare institutions’ revenue structures
• June and July performance as targets for mid-term reporting necessitates rapid data response capabilities
• Need for detailed examination of the impact of new assessment items on business value evaluation
• Importance of reviewing business succession plans in light of revision trends

Practical Questions Arising from This News

• When will the specific calculation standards and evaluation details for the “Base Rate” assessment fee be clarified?
• Given that June and July performance are subject to the mid-term report, what is the approximate preparation period prior to this?
• How will the trend of this “Base Rate” assessment fee impact the future M&A market for medical institutions?

“Should I Consult?” If You Feel This Way

Trends in medical fee revisions directly impact the profitability and future business value of medical institutions. The introduction of new assessment items like the “Base Rate” assessment fee provides an excellent opportunity for management considering business succession to re-evaluate their own institutions. Consulting with experts, including the possibility of M&A, on how their institution’s strengths and weaknesses will be positioned under the new assessment criteria can lead to the development of a more strategic business succession plan.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a complete success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultation here